China regulator confesses invalid tests; GE recalls dangerous ventilators; Pfizer recalls cough syrup;

> The FDA says Pfizer ($PFE) is voluntarily recalling its Robitussin DM cough syrup because of dosing inaccuracies for children. Story

> The FDA has assigned its most serious designation to GE Healthcare's ($GE) recall of Aestiva/5 7900, warning that a flaw in the devices could lead to circulatory shock and death. Story

> The FDA smacked Siemens Healthcare with the second warning letter in a month concerning quality and manufacturing issues with some of its diagnostics products. Story

> An FDA 483 inspection of Exemplar Pharmaceuticals of Fall River, MA, found the aerosol drugmaker lacked adequate controls to ensure consistent mixtures of its products. FDA report

And Finally... A Chinese agency acknowledged that invalid testing led it to say that vanillin had been found in baby formula from companies including Mead Johnson. Story

Webinar

Using AI and RWD to Uncover Rare Disease Insights, Accelerate Commercialization and Improve Patient Outcomes

Wednesday, March 24 | 2pm ET / 11am PT

Learn how IPM.ai transformed real world data into real world insights to assist Audentes in their development of AT132 for the treatment of XLMTM. The session reviews how IPM.ia and Audentes collaborated to uncover the XLMTM patient population.